Michael Link
Therapy for Pediatric Hodgkin Lymphoma
Contact Information
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Brief
With the success of current chemotherapy for Hodgkin's disease, the goal of this protocol is to maintain the currently successful cure rate and reduce treatment related side effects and long term toxicity. The main purpose of this study is to estimate the event free survival of patients treated with risk-adapted therapy compared to historical controls.
Recruiting Status:
RecruitingStanford Recruiting Status:
RecruitingCondition(s):
Intervention(s):
- Drug: VAMP Chemotherapy (Favorable Risk)
- Drug: Stanford V Chemotherapy (Unfavorable Risk)
- Drug: Radiation therapy
Phase:
Phase 3Eligibility
Ages Eligible for Study:
Any Age to 21 yearsGenders Eligible for Study:
Male and FemaleHealth of Volunteers:
People with the conditions listed in this trial can participate as controls.Key Inclusion Criteria:
- Histologically confirmed, previously untreated Hodgkin's disease (Patients receiving limited emergent radiation therapy or steroid therapy because of cardiopulmonary decompensation or spinal cord compression will be eligible for protocol enrollment).
- Age: 21 years of age or younger
- Stage: Ann Arbor stages
- No prior treatment
- No pregnant or nursing women
Key Exclusion Criteria:
- Pregnant or nursing women
Additional Study Details
Official Title:
Risk-Adapted Therapy for Pediatric Hodgkin's DiseaseAnticipated start date:
2/8/2000Lead Sponsor:
St. Jude ChildrenCollaborator(s):
- Maine Children's Cancer Program
- Massachusetts General Hospital
- Dana-Farber Cancer Institute
Investigator(s):
Study Type:
InterventionalPurpose:
TreatmentAllocation:
Non-randomizedMasking:
OpenControl:
noneAssignment:
Single GroupEndpoints:
EfficacyPrimary Outcomes:
- Event-free survival
Secondary Outcomes:
- To study patients' quality of life during and after treatment.
Total Number to be Enrolled:
250Total Number to be Enrolled at Stanford:
50More Information
Secondary ID(s):
- 74498
- HOD99
- NCT00145600
- PEDSHOD99
Locations & Contacts
Stanford Locations & Contacts:
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Non-Stanford Locations:
The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.
This listing was last updated:
6/5/2009PLEASE NOTE:
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.
Help